Sask. lab says its COVID-19 vaccine candidate has been found safe, issues open call for volunteers to receive it
The COVID-19 vaccine developed by the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan is safe, the lab announced Wednesday.
The most common reactions from the Phase 1 clinical trial for the vaccine, named COVAC-2, were a headache and mild injection site pain, which VIDO says are common after most immunizations.
In addition, even the lowest vaccine dose significantly increased the participants’ antibody levels, including neutralizing antibodies against SARS-CoV-2, VIDO says.
“The data continues to demonstrate the safety of our subunit vaccine COVAC-2,” Dr. Volker Gerdts, director and CEO of VIDO, said in a news release.
“We are encouraged by the vaccine’s ability to generate a significant immune response, even at the lowest dose tested.”
Subunit vaccines such as COVAC-2 contain purified viral proteins that are not infectious and the technology offers a history of safety and ease of storage and transport, VIDO says.
Participants continue to be recruited for the clinical trial in Halifax and a new clinical trial site will also open in Saskatoon later this summer.
Those 18 years and older who have not been infected with COVID-19 or received an authorized COVID-19 vaccine are eligible to volunteer.
They can contact the Clinical Trial Support Unit at ctsu@usask.ca or 306-978-8300.
CTVNews.ca Top Stories
More than 115 cases of eye damage reported in Ontario after solar eclipse
More than 115 people who viewed the solar eclipse in Ontario earlier this month experienced eye damage after the event, according to eye doctors in the province.
B.C. seeks ban on public drug use, dialing back decriminalization
The B.C. NDP has asked the federal government to recriminalize public drug use, marking a major shift in the province's approach to addressing the deadly overdose crisis.
Last letters of pioneering climber who died on Everest reveal dark side of mountaineering
George Mallory is renowned for being one of the first British mountaineers to attempt to scale the dizzying heights of Mount Everest during the 1920s. Nearly a century later, newly digitized letters shed light on Mallory’s hopes and fears about ascending Everest.
Orca calf that was trapped in B.C. lagoon for weeks swims free
An orca whale calf that has been stranded in a B.C. lagoon for weeks after her pregnant mother died swam out on her own early Friday morning.
Sophie Gregoire Trudeau on navigating post-political life, co-parenting and freedom
Sophie Gregoire Trudeau says there is 'still so much love' between her and Prime Minister Justin Trudeau, as they navigate their post-separation relationship co-parenting their three children.
'I was scared': Ontario man's car repossessed after missing two repair loan payments
An Ontario man who took out a loan to pay for auto repairs said his car was repossessed after he missed two payments.
Powerful tornado tears across Nebraska, weather service warns of 'catastrophic' damage
Devastating tornadoes tore across parts of eastern Nebraska and northeast Texas Friday as a multi-day severe thunderstorm event ramped up in the central United States, injuring at least three people.
Toxic testing standoff: Family leaves house over air quality
A Sherwood Park family says their new house is uninhabitable. The McNaughton's say they were forced to leave the house after living there for only a week because contaminants inside made it difficult to breathe.
Trump's lawyers try to discredit testimony of prosecution's first witness in hush money trial
Donald Trump's defence team attacked the credibility Friday of the prosecution's first witness in his hush money case, seeking to discredit testimony detailing a scheme between Trump and a tabloid to bury negative stories to protect the Republican's 2016 presidential campaign.